Diagnosis and Treatment of Cutaneous Adverse Effects of Targeted Therapy, Antibody-Drug Conjugates, and Immunotherapy in Cancer Patients: A National Consensus Statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
January 2026
in “
Clinical & Translational Oncology
”
cutaneous adverse effects targeted cancer therapies antibody-drug conjugates immunotherapy papulopustular eruption skin xerosis hand-foot skin reactions hair disorders nail alterations skin pigmentation changes emollients photoprotection tetracyclines PPE minoxidil platelet-rich plasma alopecia immune checkpoint inhibitors skin toxicities Rogaine PRP
Studysummary This expert consensus statement highlights that while targeted cancer therapies significantly improve patient survival, they often result in various skin toxicities, underscoring the need for early diagnosis, management, and multidisciplinary care to maintain patients' quality of life and ensure treatment continuity.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on link.springer.com →